208 related articles for article (PubMed ID: 17224538)
1. Visual screening for malignant melanoma: a cost-effectiveness analysis.
Losina E; Walensky RP; Geller A; Beddingfield FC; Wolf LL; Gilchrest BA; Freedberg KA
Arch Dermatol; 2007 Jan; 143(1):21-8. PubMed ID: 17224538
[TBL] [Abstract][Full Text] [Related]
2. Screening for proteinuria in US adults: a cost-effectiveness analysis.
Boulware LE; Jaar BG; Tarver-Carr ME; Brancati FL; Powe NR
JAMA; 2003 Dec; 290(23):3101-14. PubMed ID: 14679273
[TBL] [Abstract][Full Text] [Related]
3. Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs.
Paltiel AD; Walensky RP; Schackman BR; Seage GR; Mercincavage LM; Weinstein MC; Freedberg KA
Ann Intern Med; 2006 Dec; 145(11):797-806. PubMed ID: 17146064
[TBL] [Abstract][Full Text] [Related]
4. Lung cancer screening with helical computed tomography in older adult smokers: a decision and cost-effectiveness analysis.
Mahadevia PJ; Fleisher LA; Frick KD; Eng J; Goodman SN; Powe NR
JAMA; 2003 Jan; 289(3):313-22. PubMed ID: 12525232
[TBL] [Abstract][Full Text] [Related]
5. Cost-Effectiveness of Melanoma Screening in Inflammatory Bowel Disease.
Anderson AJM; Ferris LK; Binion DG; Smith KJ
Dig Dis Sci; 2018 Oct; 63(10):2564-2572. PubMed ID: 29948569
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of screening for anal squamous intraepithelial lesions and anal cancer in human immunodeficiency virus-negative homosexual and bisexual men.
Goldie SJ; Kuntz KM; Weinstein MC; Freedberg KA; Palefsky JM
Am J Med; 2000 Jun; 108(8):634-41. PubMed ID: 10856411
[TBL] [Abstract][Full Text] [Related]
7. Screening for malignant melanoma: A cost-effectiveness analysis.
Freedberg KA; Geller AC; Miller DR; Lew RA; Koh HK
J Am Acad Dermatol; 1999 Nov; 41(5 Pt 1):738-45. PubMed ID: 10534637
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
Manser R; Dalton A; Carter R; Byrnes G; Elwood M; Campbell DA
Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317
[TBL] [Abstract][Full Text] [Related]
9. The cost-effectiveness of screening for type 2 diabetes. CDC Diabetes Cost-Effectiveness Study Group, Centers for Disease Control and Prevention.
JAMA; 1998 Nov; 280(20):1757-63. PubMed ID: 9842951
[TBL] [Abstract][Full Text] [Related]
10. Expanded screening for HIV in the United States--an analysis of cost-effectiveness.
Paltiel AD; Weinstein MC; Kimmel AD; Seage GR; Losina E; Zhang H; Freedberg KA; Walensky RP
N Engl J Med; 2005 Feb; 352(6):586-95. PubMed ID: 15703423
[TBL] [Abstract][Full Text] [Related]
11. Screening for type 2 diabetes mellitus: a cost-effectiveness analysis.
Hoerger TJ; Harris R; Hicks KA; Donahue K; Sorensen S; Engelgau M
Ann Intern Med; 2004 May; 140(9):689-99. PubMed ID: 15126252
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of different screening strategies for abdominal aortic aneurysm.
Wanhainen A; Lundkvist J; Bergqvist D; Björck M
J Vasc Surg; 2005 May; 41(5):741-51; discussion 751. PubMed ID: 15886653
[TBL] [Abstract][Full Text] [Related]
13. Screening for Melanoma in Men: a Cost-Effectiveness Analysis.
Adamson AS; Jarmul JA; Pignone MP
J Gen Intern Med; 2020 Apr; 35(4):1175-1181. PubMed ID: 31705474
[TBL] [Abstract][Full Text] [Related]
14. Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus.
Vijan S; Hofer TP; Hayward RA
JAMA; 2000 Feb; 283(7):889-96. PubMed ID: 10685713
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of screening and vaccinating Asian and Pacific Islander adults for hepatitis B.
Hutton DW; Tan D; So SK; Brandeau ML
Ann Intern Med; 2007 Oct; 147(7):460-9. PubMed ID: 17909207
[TBL] [Abstract][Full Text] [Related]
16. Newborn screening by tandem mass spectrometry for medium-chain Acyl-CoA dehydrogenase deficiency: a cost-effectiveness analysis.
Venditti LN; Venditti CP; Berry GT; Kaplan PB; Kaye EM; Glick H; Stanley CA
Pediatrics; 2003 Nov; 112(5):1005-15. PubMed ID: 14595039
[TBL] [Abstract][Full Text] [Related]
17. Cost-Effectiveness Analysis of a Skin Awareness Intervention for Early Detection of Skin Cancer Targeting Men Older Than 50 Years.
Gordon LG; Brynes J; Baade PD; Neale RE; Whiteman DC; Youl PH; Aitken JF; Janda M
Value Health; 2017 Apr; 20(4):593-601. PubMed ID: 28408001
[TBL] [Abstract][Full Text] [Related]
18. The cost-utility of screening for depression in primary care.
Valenstein M; Vijan S; Zeber JE; Boehm K; Buttar A
Ann Intern Med; 2001 Mar; 134(5):345-60. PubMed ID: 11242495
[TBL] [Abstract][Full Text] [Related]
19. Screening for Chlamydia trachomatis in women 15 to 29 years of age: a cost-effectiveness analysis.
Hu D; Hook EW; Goldie SJ
Ann Intern Med; 2004 Oct; 141(7):501-13. PubMed ID: 15466767
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of different screening strategies for osteoporosis in postmenopausal women.
Nayak S; Roberts MS; Greenspan SL
Ann Intern Med; 2011 Dec; 155(11):751-61. PubMed ID: 22147714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
